DOD Peer Reviewed Cancer Idea Award

The summary for the DOD Peer Reviewed Cancer Idea Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.

DOD Peer Reviewed Cancer Idea Award: The PRCRP Idea Award mechanism was first offered in FY09. Since then, 38 Idea Award applications have been received, and 6 have been recommended for funding. The Idea Award is intended to promote the exploration of ideas that are still in the early stages of development yet have the potential to yield high-impact results and open new avenues of investigation in the relevant FY10 PRCRP Topic Areas. This mechanism supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements. Preliminary data are not required. However, research projects should include a well-formulated, testable hypothesis based on a strong scientific rationale. DOD FY10 Peer Reviewed Cancer Research Program Idea Award 3 Research involving human subject participation is permitted under this funding opportunity but is restricted to studies without clinical trials. Clinical trials are not permitted under this award mechanism. In general, a clinical trial is defined as a prospective study where an intervention (e.g., a device, drug, behavioral, surgical procedure) is tested on human subjects for a measurable outcome. Correlative Human Subject Use (clinical research) studies are permitted, and the study may be associated with a Clinical trial but it does not seek the main outcomes of the clinical trial. Correlative studies are defined as a prospective or retrospective collection of human anatomical substances (tissue, blood, nail clippings, bone marrow, behavioral documentation, etc.) to be used in research to answer a question regarding the disease and /or interventions. It does not include the direct testing for the outcome of any intervention for the prevention, diagnosis, treatment, or evaluation of the quality of life of the patient. Correlative Human Subject Use may require informed consent of the human subject, and may include identifiable information. Refer to the General Application Instructions, Appendix 5, for additional information about studies involving human subjects, human subjects data, or human anatomical substances. For FY10, the PRCRP Idea Award will only consider applications that address one or more of the FY10 PRCRP Topic Areas.